Retraction
Clinical trials in Alzheimer's disease': immunotherapy approaches
Paper Information
Record ID:
30541
Journal:
Publication Date:
August 30, 2011
Retraction Date:
July 06, 2021
(4.4 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Alzheimer’s Disease Clinical Research Centre, Gérontopôle, Toulouse University Hospital, FranceCountry:
🇫🇷 FranceArticle Type:
Publisher:
Wiley
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (145)
145
Total Citations6
Post-Retraction(4.1%)
138
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
5
After 2+ years
1061
Days since retraction (latest)
Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer’s Disease: What are the Roadblocks and How Can They Be Overcome?1
Avijit Banik, Richard E. Brown, James R. Bamburg et al. (17 authors)
Journal of Alzheimer s Disease
Published: Aug 2015
96 citations
96 citations
2156 days before retraction
Alzheimer's disease vaccine development: A new strategy focusing on immune modulation
Dante J. Marciani
Journal of Neuroimmunology
Published: Aug 2015
43 citations
43 citations
2158 days before retraction
Correlations between Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment
Agneta Nordberg, Ahmadul Kadir, Niels Andreasen et al. (8 authors)
Journal of Alzheimer s Disease
Open Access
Published: Aug 2015
8 citations
8 citations
2164 days before retraction
A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease
Michael G. Agadjanyan, Nikolai Petrovsky, Anahit Ghochikyan
Alzheimer s & Dementia
Open Access
Published: Jul 2015
65 citations
65 citations
2181 days before retraction
The Amyloid Precursor Protein Controls PIKfyve Function
Zita Balklava, Christian Niehage, Heather Currinn et al. (8 authors)
PLoS ONE
Open Access
Published: Jun 2015
21 citations
21 citations
2198 days before retraction
Nanomedicine for the Treatment of Alzheimer’s Disease
Maria Gregori, Massimo Masserini, Simona Mancini
Nanomedicine
Published: Apr 2015
92 citations
92 citations
2288 days before retraction
Dementia and use of drugs : economic modelling and population-based studies
Anders Sköldunger
Unknown Journal
Published: Jan 2015
1 citation
1 citation
2349 days before retraction
Co-immunization with DNA and protein mixture: A safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice
Si Liu, Danyang Shi, Haichao Wang et al. (6 authors)
Scientific Reports
Open Access
Published: Jan 2015
27 citations
27 citations
2365 days before retraction
Protein Misfolding, Neurodegeneration and Tau
Pierfausto Seneci
Elsevier eBooks
Published: Jan 2015
1 citation
1 citation
2378 days before retraction
Immunotherapeutic Approaches Against Amyloid-β in Drug Discovery for Alzheimer’s Disease
Seung‐Hoon Yang, Jiyoon Kim, Young Soo Kim
Springer eBooks
Published: Jan 2015
2378 days before retraction
Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer’s Disease
Arjun Thapa, Eva Y.
Advances in experimental medicine and biology
Published: Jan 2015
42 citations
42 citations
2378 days before retraction
Proteopathies: Biological, Molecular and Clinical Perspectives
Rimpy Kaur Chowhan, Tanveer Ali Dar, Laishram Rajendrakumar Singh
Springer eBooks
Published: Jan 2015
1 citation
1 citation
2378 days before retraction
Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future
Harald Hampel, Lon S. Schneider, Ezio Giacobini et al. (10 authors)
Expert Review of Neurotherapeutics
Published: Dec 2014
71 citations
71 citations
2386 days before retraction
Rarity of the Alzheimer Disease–Protective<i>APP</i>A673T Variant in the United States
Li-San Wang, Adam C. Naj, Robert Graham et al. (100 authors)
JAMA Neurology
Open Access
Published: Dec 2014
45 citations
45 citations
2388 days before retraction
Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease
Fernando Goñi, Candace K. Mathiason, Lucía Yim et al. (17 authors)
Vaccine
Open Access
Published: Dec 2014
71 citations
71 citations
2389 days before retraction
A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory
Hayk Davtyan, Anahit Ghochikyan, Armine Hovakimyan et al. (9 authors)
Journal of Neuroimmunology
Open Access
Published: Oct 2014
5 citations
5 citations
2455 days before retraction
Neurodegenerative disorders
Susanna Pietropaolo, Frans Sluyter, Wim E. Crusio
Cambridge University Press eBooks
Published: Sep 2014
1 citation
1 citation
2476 days before retraction
Amyloid β-peptide and Alzheimer's disease
David Allsop, Jennifer Mayes
Essays in Biochemistry
Published: Aug 2014
20 citations
20 citations
2514 days before retraction
Amyloid-β Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease
Michael Hanenberg, Jordan McAfoose, Luka Kulic et al. (13 authors)
Journal of Biological Chemistry
Open Access
Published: Aug 2014
19 citations
19 citations
2519 days before retraction
Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
Shuko Takeda, Naoyuki Sato, Ryuichi Morishita
Frontiers in Aging Neuroscience
Open Access
Published: Jul 2014
216 citations
216 citations
2534 days before retraction
Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation
Monique Richter, Agneta Mewes, Manuela Fritsch et al. (6 authors)
Vaccines
Open Access
Published: Jul 2014
14 citations
14 citations
2534 days before retraction
Lymphocytes and autoimmunity after spinal cord injury
T. Bucky Jones
Experimental Neurology
Published: Jul 2014
68 citations
68 citations
2553 days before retraction
Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases
Fatemeh Shojaei, Naemeh Tavakolinia, Adeleh Divsalar et al. (7 authors)
Journal of the Iranian Chemical Society
Published: Jul 2014
3 citations
3 citations
2554 days before retraction
Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients
Joel C. Watts, Carlo Condello, Jan Stöhr et al. (10 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Jun 2014
265 citations
265 citations
2563 days before retraction
Strikingly Reduced Amyloid Burden and Improved Behavioral Performance in Alzheimer's Disease Mice Immunized with Recombinant Chimeric Vaccines by Hexavalent Foldable Aβ1-15 Fused to Toxin-Derived Carrier Proteins
Yun‐Zhou Yu, Wenbin Wang, Ao Chen et al. (11 authors)
Journal of Alzheimer s Disease
Published: Jun 2014
12 citations
12 citations
2589 days before retraction
Every Silver Lining has a Cloud: The Scientific and Animal Welfare Issues Surrounding a New Approach to the Production of Transgenic Animals
Robert D. Combes, Michael Balls
Alternatives to Laboratory Animals
Open Access
Published: May 2014
11 citations
11 citations
2623 days before retraction
The Flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights from In Silico and In Vivo Studies
Sandeep Kumar Singh, Ruchi Gaur, Akhil Kumar et al. (6 authors)
Neurotoxicity Research
Published: Apr 2014
36 citations
36 citations
2650 days before retraction
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
Joakim Hertze, Katarina Nägga, Lennart Minthon et al. (4 authors)
BMC Neurology
Open Access
Published: Apr 2014
51 citations
51 citations
2653 days before retraction
A Generic Method for Design of Oligomer-Specific Antibodies
Kristoffer Brännström, Malin Lindhagen‐Persson, Anna L. Gharibyan et al. (10 authors)
PLoS ONE
Open Access
Published: Mar 2014
44 citations
44 citations
2674 days before retraction
New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies
Dante J. Marciani
Drug Discovery Today
Published: Mar 2014
32 citations
32 citations
2678 days before retraction
The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates
Hayk Davtyan, Anahit Ghochikyan, Irina Petrushina et al. (7 authors)
Alzheimer s & Dementia
Open Access
Published: Feb 2014
30 citations
30 citations
2693 days before retraction
Immunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines
Hayk Davtyan, Andrew Bacon, Irina Petrushina et al. (7 authors)
Human Vaccines & Immunotherapeutics
Open Access
Published: Feb 2014
24 citations
24 citations
2700 days before retraction
Paper citing Clinical trials in Alzheimer's disease': immunothe...
Unknown Authors
Unknown Journal
Published: Feb 2014
2712 days before retraction
Alzheimer Disease and Cellular Mechanisms of Memory Storage
Yuri I. Arshavsky
Journal of Neuropathology & Experimental Neurology
Open Access
Published: Jan 2014
18 citations
18 citations
2713 days before retraction
Long-Term Oral Administration of Hop Flower Extracts Mitigates Alzheimer Phenotypes in Mice
Norio Sasaoka, Megumi Sakamoto, Shoko Kanemori et al. (7 authors)
PLoS ONE
Open Access
Published: Jan 2014
30 citations
30 citations
2715 days before retraction
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
Ángel Agís-Torres, Mónica Söllhuber, María Victoria Fernández et al. (4 authors)
Current Neuropharmacology
Open Access
Published: Jan 2014
181 citations
181 citations
2721 days before retraction
Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers
Lina Adwan, Gehad M. Subaiea, Nasser H. Zawia
Neuropharmacology
Open Access
Published: Jan 2014
45 citations
45 citations
2723 days before retraction
Pan-Amyloid Oligomer Specific scFv Antibody Attenuates Memory Deficits and Brain Amyloid Burden in Mice with Alzheimer’s Disease
Min Zhao, Shaowei Wang, Yujiong Wang et al. (9 authors)
Current Alzheimer Research
Published: Jan 2014
25 citations
25 citations
2738 days before retraction
Plant-based vaccines for Alzheimer's disease: an overview
Sergio Rosales-Méndoza, Néstor Rubio‐Infante, Sergio Zarazúa et al. (6 authors)
Expert Review of Vaccines
Published: Jan 2014
11 citations
11 citations
2741 days before retraction
Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
Deborah Doens, Patricia L. Fernández
Journal of Neuroinflammation
Open Access
Published: Jan 2014
299 citations
299 citations
2743 days before retraction
Pharmacogenomics of Alzheimer’s Disease: Novel Therapeutic Strategies for Drug Development
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas et al. (5 authors)
Methods in molecular biology
Published: Jan 2014
74 citations
74 citations
2743 days before retraction
Glycosphingolipids in the Regulation of the Nervous System
Koichi Furukawa, Yusuke Ohmi, Yuki Ohkawa et al. (5 authors)
Advances in neurobiology
Published: Jan 2014
30 citations
30 citations
2743 days before retraction
Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
Sun-Ho Han, Inhee Mook‐Jung
Journal of Korean Medical Science
Open Access
Published: Jan 2014
23 citations
23 citations
2743 days before retraction
Personalized Medicine of Alzheimer’s Disease
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas
Elsevier eBooks
Published: Jan 2014
14 citations
14 citations
2743 days before retraction
Modulation of BACE1 Activity as a Potential Therapeutic Strategy for Treating Alzheimer’s Disease
David W. Klaver, Giuseppina Tesco
Elsevier eBooks
Published: Jan 2014
1 citation
1 citation
2743 days before retraction
Targets and Small Molecules Against Tauopathies. Part 1: From Genes to Soluble, Aggregation-Prone Tau Proteins
Pierfausto Seneci
Elsevier eBooks
Published: Jan 2014
2743 days before retraction
Plant-based vaccines for Alzheimer's disease: an
O Dania, Leticia Moreno‐Fierros
Unknown Journal
Published: Jan 2014
2743 days before retraction
透過金屬離子結合、家族性突變型、以及奈米金粒子瞭解阿茲海默症乙型類澱粉蛋白纖維化的複雜性
廖宜鴻
Unknown Journal
Published: Jan 2014
2743 days before retraction
Evaluating a new drug to combat alzheimer's disease.
Siyabonga G. Sibiya
Unknown Journal
Published: Jan 2014
2743 days before retraction
RECENT TRENDS IN TREATING NEURONAL PROTEINOPATHIES
Rimpy Kaur Chowhan, Marina Warepam, Tanveer Ali Dar et al. (4 authors)
Journal of Proteins and Proteomics
Published: Dec 2013
5 citations
5 citations
2755 days before retraction
Quick Stats
Total Citations:
145
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025